Cubist Systematic Strategies’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,030
| Closed | -$983K | – | 4973 |
|
|
2022
Q3 | $983K | Sell |
19,030
-44,569
| -70% | -$1.84M | 0.01% | 2637 |
|
|
2022
Q2 | $1.58M | Buy |
63,599
+31,059
| +95% | +$685K | 0.01% | 2076 |
|
|
2022
Q1 | $816K | Sell |
32,540
-5,958
| -15% | -$167K | 0.01% | 2198 |
|
|
2021
Q4 | $1.4M | Buy |
38,498
+29,171
| +313% | +$1.02M | 0.01% | 1657 |
|
|
2021
Q3 | $159K | Sell |
9,327
-5,573
| -37% | -$86.8K | ﹤0.01% | 2644 |
|
|
2021
Q2 | $200K | Buy |
14,900
+9,963
| +202% | +$245K | ﹤0.01% | 2563 |
|
|
2021
Q1 | $253K | Sell |
4,937
-3,431
| -41% | -$206K | ﹤0.01% | 2352 |
|
|
2020
Q4 | $518K | Sell |
8,368
-3,446
| -29% | -$197K | 0.01% | 1756 |
|
|
2020
Q3 | $647K | Sell |
11,814
-51,686
| -81% | -$2.78M | 0.01% | 1587 |
|
|
2020
Q2 | $3.65M | Buy |
63,500
+59,200
| +1,377% | +$3.22M | 0.06% | 486 |
|
|
2020
Q1 | $173K | Sell |
4,300
-13,982
| -76% | -$594K | ﹤0.01% | 1788 |
|
|
2019
Q4 | $723K | Sell |
18,282
-8,499
| -32% | -$149K | 0.01% | 1358 |
|
|
2019
Q3 | $182K | Sell |
26,781
-5,589
| -17% | -$41.9K | ﹤0.01% | 1811 |
|
|
2019
Q2 | $301K | Buy |
+32,370
| New | +$375K | 0.01% | 1799 |
|
|
2018
Q3 | – | Sell |
-19,271
| Closed | -$254K | – | 2158 |
|
|
2018
Q2 | $254K | Buy |
+19,271
| New | +$230K | 0.01% | 1198 |
|
|
2017
Q1 | – | Sell |
-12,322
| Closed | -$91K | – | 1933 |
|
|
2016
Q4 | $91K | Buy |
+12,322
| New | +$88.7K | 0.01% | 1508 |
|
|
2016
Q1 | – | Sell |
-346
| Closed | -$3K | – | 1902 |
|
|
2015
Q4 | $3K | Buy |
+346
| New | +$2.45K | ﹤0.01% | 1724 |
|
Other funds holding CCXI
Cubist Systematic Strategies's CCXI Position: Q4 2022 in Review
Cubist Systematic Strategies sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 19,030 shares — an estimated $983K sold.
Cubist Systematic Strategies first reported a position in CCXI in Q4 2015 and held it in 17 quarters. The position peaked at $3.65M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Cubist Systematic Strategies reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Cubist Systematic Strategies sold 19,030 ChemoCentryx, Inc. shares in Q4 2022, an estimated $983K.
- Cubist Systematic Strategies first reported a position in ChemoCentryx, Inc. in Q4 2015 and held it in 17 quarters.
- Cubist Systematic Strategies's ChemoCentryx, Inc. position peaked at $3.65M in Q2 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.